Potential Biomarkers of the Severity of Endothelial Damage in End-stage Chronic Kidney Failure
NCT ID: NCT02857556
Last Updated: 2019-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
10 participants
INTERVENTIONAL
2014-04-17
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reduction of Oxalate and Inflammation by Hemodiafiltration vs. Hemodialysis
NCT02684656
Interactive Studies of Endstage Diabetic Dialysis Patients
NCT00175734
Changes in Renal Perfusion During Hemodialysis in Patients with End-stage Renal Disease
NCT06587997
Oxidative Stress on Muscle Dysfunction in Hemodialysis Patient
NCT02794142
Evaluating the Use of the Qidni/D Hemodialysis System by Subjects With End-Stage Renal Disease
NCT06086470
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group with stage 3 kidney failure (diabetic or not)
Blood sample
Retinal photography:
group with stage 5 kidney failure (diabetic or not)
Blood sample
dialyse
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sample
Retinal photography:
dialyse
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with national health insurance cover
* Patients aged between 18 and 75 years
* Patients with stage 3 kidney failure (30 ml/min \< cl creat \< 59 ml/min) diabetic or not
* Patients with stage 5 kidney failure (cl creat \< 15 ml/mn) diabetic or not and requiring dialysis.
Exclusion Criteria
* Pregnant or breast-feeding women
* Infection (including peritonitis in peritoneal dialysis, infection of the catheter insertion site),
* Neoplastic disease,
* Systemic diseases in flare,
* Patients positive for Human Immunodeficience Virus (HIV),
* Patients on immunosuppressants
* Patients taking antioxidants (selenium, vitamin C and/or E)
* Patient on statins
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GAMBERT Fd. Transpl 2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.